Skip to main content

Want a detailed portfolio tracker?

AC Immune (ACIU) P/E (2016 - 2026)

AC Immune (ACIU) P/E from Sep 23, 2016 to Jun 3, 2026. The TTM AC Immune (ACIU) P/E is -2.87. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of AC Immune (ACIU)

YearP/EChange
2026-2.87-21.44%
2025-3.65-24.01%
2024-4.80-14.46%
2023-5.62+168.54%
2022-2.09-55.74%
2021-4.72-14.63%
2020-5.53-140.60%
201913.63-219.69%
2018-11.39-43.73%
2017-20.24-74.05%
2016-78.01N/A

Comparison AC Immune (ACIU) P/E with competitors

AC Immune (ACIU) P/E is -2.87.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.06%
NBYStablecoin Development Corp0.10-103.57%
ENLVEnlivex Therapeutics Ltd0.15-105.24%
FGENFibroGen Inc0.24-108.37%
TRAWTraws Pharma Inc0.47-116.49%
FBIOFortress Biotech Inc0.71-124.62%
CHRSCoherus Biosciences Inc0.98-134.11%
ORMPOramed Pharmaceuticals Inc1.47-151.39%
AGENAgenus Inc2.05-171.44%
VIVSVivoSim Labs Inc2.54-188.43%
INVAInnoviva Inc3.19-211.20%
CRMDCorMedix Inc3.65-227.14%
ABEOAbeona Therapeutics Inc4.20-246.65%
VXRTVaxart Inc4.26-248.62%
CVACCureVac N.V.4.45-255.04%
SRPTSarepta Therapeutics Inc4.62-261.27%
GLPGGalapagos NV4.86-269.45%
RIGLRigel Pharmaceuticals4.92-271.57%
ZVRAZevra Therapeutics Inc4.97-273.47%
ABUSArbutus Biopharma Corp5.69-298.57%
CGENCompugen Ltd7.38-357.51%
AUPHAurinia Pharmaceuticals Inc9.25-422.64%
OMEROmeros Corporation9.88-444.68%
PLXProtalix BioTherapeutics Inc9.91-445.58%
SPROSpero Therapeutics Inc10.73-474.37%
ADMAAdma Biologics Inc11.33-495.15%
SVASinovac Biotech Ltd11.44-498.83%
TBPHTheravance Biopharma Inc11.78-510.71%
HRMYHarmony Biosciences Holdings Inc12.18-524.79%
TGTXTG Therapeutics Inc13.18-559.63%
INCYIncyte Corp13.38-566.70%
SABSSAB Biotherapeutics Inc14.06-590.26%
XOMAXOMA Corp14.95-621.21%
REGNRegeneron Pharmaceuticals Inc14.98-622.43%
PBYIPuma Biotechnology Inc15.05-624.88%
EXELExelixis Inc15.79-650.84%
NAGENiagen Bioscience Inc16.35-670.38%
CPRXCatalyst Pharmaceuticals Inc17.34-704.90%
MDXGMimedx Group Inc17.38-705.96%
ARGXArgen X SE23.07-904.62%
HALOHalozyme Therapeutics Inc23.20-909.12%
XOMAOXOMA Corp25.34-983.90%
VRTXVertex Pharmaceuticals Inc25.66-994.75%
XOMAPXOMA Corp25.67-995.24%
CTMXCytomX Therapeutics Inc25.70-996.21%
ASNDAscendis Pharma A/S26.35-1019.10%
RPRXRoyalty Pharma plc - Class A27.50-1058.90%
SLNOSoleno Therapeutics Inc29.02-1111.91%
LGNDLigand Pharmaceuticals Inc - Class B30.19-1152.75%
BMRNBiomarin Pharmaceutical Inc37.51-1408.07%
APLSApellis Pharmaceuticals Inc39.02-1460.86%
KRYSKrystal Biotech Inc39.70-1484.45%
GMABGenmab40.20-1502.10%
ONCBeiGene Ltd67.03-2437.57%
TECHBio-Techne Corp68.59-2492.25%
VCELVericel Corp80.63-2911.95%
PHARPharming Group N.V.87.74-3159.94%
ALNYAlnylam Pharmaceuticals Inc124.93-4457.07%
TLXTelix Pharmaceuticals Ltd139.89-4978.69%
CORTCorcept Therapeutics Inc158.39-5623.83%